Inventor · disambiguated record
Katsuhiro Imaki
Also filed as: IMAKI KATSUHIRO
24 granted patents·193 citations·filing 1983–1995
95Inventor score
Top patents by PatentIndex Score
24 records- 0192US5376655ADerivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as an active ingredientONO PHARMACEUTICAL CO·Filed 1993·Granted Dec 27, 1994·40 cites·2 claims
- 0289US5017610ADerivatives of p-substituted phenyl ester of pivalic acidONO PHARMACEUTICAL CO·Filed 1989·Granted May 21, 1991·22 cites·3 claims
- 0386US4935446AProstaglandin analogues, process for their preparation and pharmaceutical compositions containing themONO PHARMACEUTICAL CO·Filed 1989·Granted Jun 19, 1990·37 cites·15 claims
- 0478US4843094ADerivatives of p-guantidinobenzoic acid and pharmaceutical agents containing them as active ingredientONO PHARMACEUTICAL CO·Filed 1986·Granted Jun 27, 1989·13 cites·3 claims
- 0573US5359121AGlycine derivative monosodium salt tetrahydrateONO PHARMACEUTICAL CO·Filed 1994·Granted Oct 25, 1994·12 cites·1 claims
- 0671US5336681ADerivatives of p-substituted phenyl ester of pivalic acidONO PHARMACEUTICAL CO·Filed 1992·Granted Aug 9, 1994·10 cites·7 claims
- 0768US4562207AProstaglandin analogueONO PHARMACEUTICAL CO·Filed 1984·Granted Dec 31, 1985·12 cites·5 claims
- 0866US5247084ADerivatives of p-guanidinobenzoic acidONO PHARMACEUTICAL CO·Filed 1991·Granted Sep 21, 1993·7 cites·2 claims
- 0965US5403850ADerivatives of P-substituted phenyl ester of pivalic acidONO PHARMACEUTICAL CO·Filed 1994·Granted Apr 4, 1995·7 cites·11 claims
- 1065US5077428APharmacologically active derivatives of p-guanidinobenzoic acidONO PHARMACEUTICAL CO·Filed 1990·Granted Dec 31, 1991·7 cites·2 claims
- 1158US4975464ATreatment of diseases caused by abnormal action of elastaseIMAKI KATSUHIRO·Filed 1989·Granted Dec 4, 1990·6 cites·2 claims
- 1254US4640931A3-(indian-5-yloxy (or thio)) cyclopentanecarboxylic acid analoguesONO PHARMACEUTICAL CO·Filed 1985·Granted Feb 3, 1987·6 cites·7 claims
- 1351US4464388AUse of prostaglandin analogues to treat cytodamageONO PHARMACEUTICAL CO·Filed 1983·Granted Aug 7, 1984·5 cites·30 claims
- 1440US4473587AProstaglandin E1 analoguesONO PHARMACEUTICAL CO·Filed 1983·Granted Sep 25, 1984·2 cites·11 claims
- 1538US4888351A3-phenoxy (or phenylthia) cyclopentanecarbonylamino acid analoguesONO PHARMACEUTICAL CO·Filed 1988·Granted Dec 19, 1989·1 cites·5 claims
- 1638US4783476A3-Phenoxy (or phenylthio)-cyclopentanecarbonylamino acid analoguesONO PHARMACEUTICAL CO·Filed 1986·Granted Nov 8, 1988·1 cites·6 claims
- 1734US4503068AUse of prostaglandin analogues to treat cytodamageONO PHARMACEUTICAL CO·Filed 1983·Granted Mar 5, 1985·4 cites·17 claims
- 1833US5294723ASalts of glucopyranose derivatives and its intermediateONO PHARMACEUTICAL CO·Filed 1993·Granted Mar 15, 1994·1 cites·1 claims
- 1933US5023268A3-phenoxy (or phenylthio)-cyclopentanecarbonylamino acid analoguesONO PHARMACEUTICAL CO·Filed 1989·Granted Jun 11, 1991·0 cites·6 claims
- 2032US4829078A3-phenoxy (or phenylthio)--cyclopentanecarbonylamino acid analoguesONO PHARMACEUTICAL CO·Filed 1988·Granted May 9, 1989·0 cites·6 claims
- 2131US5109021AProstaglandin analogues, process for their preparation and pharmaceutical compositions containing themONO PHARMACEUTICAL CO·Filed 1990·Granted Apr 28, 1992·0 cites·9 claims
- 2230US5733927ASalts of glucopyranose derivative and solutions of the sameONO PHARMACEUTICAL CO·Filed 1995·Granted Mar 31, 1998·0 cites·9 claims
- 2329US4916147A3-[(4-Aroyl) phenoxy (or phenylthio)]-cyclopentanecarboxylic acid analogues and treatment of cerebral edema therewithONO PHARMACEUTICAL CO·Filed 1986·Granted Apr 10, 1990·0 cites·6 claims
- 2425US5221689AProstaglandin analogues, processes for their preparation and pharmaceutical compositions containing themONO PHARMACEUTICAL CO·Filed 1992·Granted Jun 22, 1993·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Katsuhiro Imaki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →